Brazil Insomnia Therapeutics Market Size & Outlook

The insomnia therapeutics market in Brazil is expected to reach a projected revenue of US$ 75.2 million by 2030. A compound annual growth rate of 4.8% is expected of Brazil insomnia therapeutics market from 2025 to 2030.
Revenue, 2024 (US$M)
$57.0
Forecast, 2030 (US$M)
$75.2
CAGR, 2025 - 2030
4.8%
Report Coverage
Brazil

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Brazil insomnia therapeutics market, 2018-2030 (US$M)

Brazil insomnia therapeutics market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Brazil insomnia therapeutics market highlights

  • The Brazil insomnia therapeutics market generated a revenue of USD 57.0 million in 2024 and is expected to reach USD 75.2 million by 2030.
  • The Brazil market is expected to grow at a CAGR of 4.8% from 2025 to 2030.
  • In terms of segment, benzodiazepines was the largest revenue generating type in 2024.
  • Benzodiazepines is the most lucrative type segment registering the fastest growth during the forecast period.


Insomnia therapeutics market data book summary

Market revenue in 2024USD 57.0 million
Market revenue in 2030USD 75.2 million
Growth rate4.8% (CAGR from 2025 to 2030)
Largest segmentBenzodiazepines
Fastest growing segmentBenzodiazepines
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationBenzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists
Key market players worldwideTakeda Pharmaceutical Co Ltd, Vanda Pharmaceuticals, Merck & Co Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Mylan N.V., Sumitomo Pharma Co Ltd, Sanofi SA, Paratek Pharmaceuticals, Ebb Therapeutics


Other key industry trends

  • In terms of revenue, Brazil accounted for 2.0% of the global insomnia therapeutics market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil insomnia therapeutics market is projected to lead the regional market in terms of revenue in 2030.
  • Brazil is the fastest growing regional market in Latin America and is projected to reach USD 75.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Insomnia Therapeutics Market Companies

Name Profile # Employees HQ Website
Ebb Therapeutics View profile 1-10 Pittsburgh, Pennsylvania, United States, North America https://ebbsleep.com/
Vanda Pharmaceuticals View profile 251-500 Washington, District of Columbia, United States, North America http://www.vandapharma.com
Mylan N.V. View profile - - -
Sumitomo Pharma Co Ltd View profile 6250 6-8, Doshomachi 2-chome, Chuo-ku, Osaka, Japan, 541-0045 https://www.sumitomo-pharma.com
Paratek Pharmaceuticals View profile 251-500 Boston, Massachusetts, United States, North America http://paratekpharma.com/
Takeda Pharmaceutical Co Ltd View profile 49095 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 https://www.takeda.com
Merck & Co Inc View profile 72000 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 https://www.merck.com
Sanofi SA View profile 87994 46, avenue de la Grande Armée, Paris, France, 75017 https://www.sanofi.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
Teva Pharmaceutical Industries Ltd View profile 37851 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 https://www.tevapharm.com

Brazil insomnia therapeutics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to insomnia therapeutics market will help companies and investors design strategic landscapes.


Benzodiazepines was the largest segment with a revenue share of 30.53% in 2024. Horizon Databook has segmented the Brazil insomnia therapeutics market based on benzodiazepines, nonbenzodiazepines, antidepressants, orexin antagonists, melatonin antagonists covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Brazil insomnia therapeutics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Brazil insomnia therapeutics market databook

  • Our clientele includes a mix of insomnia therapeutics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Brazil insomnia therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into Brazil insomnia therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Brazil insomnia therapeutics market size, by type, 2018-2030 (US$M)

Brazil Insomnia Therapeutics Market Outlook Share, 2024 & 2030 (US$M)

Brazil insomnia therapeutics market size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online